RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study

NCT02685007 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131

Last updated 2020-03-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to describe ease of use and satisfaction with application of the pre-rolled TachoSil in laparoscopic procedures within approved therapeutic indication as per Summary of Product Characteristics (SmPC).

Conditions

  • Laparoscopy

Interventions

OTHER

Tachosil

TachoSil is a collagen matrix that is coated with human fibrinogen and human thrombin.

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-05
Primary Completion
2017-08-14
Completion
2017-08-14

Countries

  • Austria

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02685007 on ClinicalTrials.gov